Ana Cecilia Gonzales-Luna
Research Subjects
Ana Cecilia Gonzales-Luna has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mario Cabrera-Saldaña
Unidad de Arritmias, Instituto Nacional Cardiovascular INCOR, EsSalud, Lima, Perú
4 shared publications - Angel Cueva-Parra
Unidad de arritmias, Instituto Nacional Cardiovascular, INCOR-EsSalud, Lima, Peru
3 shared publications - Anibal Diaz-Lazo
Universidad de Huánuco. Huánuco, Perú
3 shared publications - Carlos Rubén Barrientos
Hospital Nacional del Centro Daniel Alcides Carrión, Huancayo, Perú; Universidad Continental, Huancayo, Perú
3 shared publications - Carolina Guevara-Caicedo
Unidad de Arritmias, Instituto Nacional Cardiovascular INCOR, EsSalud, Lima, Perú
3 shared publications - Fernando Gamio Vega Centeno
Facultad de Medicina Humana, Universidad Nacional de San Antonio Abad del Cusco, Cusco, Perú; Hospital III EsSalud, Juliaca, Perú
3 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (3) , 243-249
Neurologic presentation unmasks arrhythmogenic channelopathy: KCNH2 variant Long-QT syndrome managed with subcutaneous implantable cardioverter-defibrillator. A case report
A previously healthy 10-year-old boy developed febrile seizure-like episodes after an appendectomy, which were diagnosed as epilepsy despite a normal electroencephalogram. He later presented with dyspnea and palpitations and was prescribed propafenone for frequent premature ventricular complexes. The electrocardiogram showed a markedly prolonged QTc interval of 550 ms with a notched T wave in lead V2. Phenytoin and propafenone were discontinued, and propranolol was initiated, but QTc prolongation persisted. The combination of severely prolonged QTc, characteristic T-wave morphology, and absence of structural heart disease redirected the diagnosis toward a repolarization channelopathy; genetic testing confirmed long-QT syndrome type 2 due to a pathogenic KCNH2 c.1814C>T variant. β-blocker therapy was optimized, QT-prolonging triggers were avoided, and a subcutaneous implantable cardioverter-defibrillator was implanted. Cascade genetic screening identified no additional KCNH2 carriers. One variant-negative sister had frequent idiopathic right ventricular outflow tract premature ventricular complexes and was referred for catheter ablation.
- 13 August 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (3) , 243-249
Open AccessNeurologic presentation unmasks arrhythmogenic channelopathy: KCNH2 variant Long-QT syndrome managed with subcutaneous implantable cardioverter-defibrillator. A case report
A previously healthy 10-year-old boy developed febrile seizure-like episodes after an appendectomy, which were diagnosed as epilepsy despite a normal electroencephalogram. He later presented with dyspnea and palpitations and was prescribed propafenone for frequent premature ventricular complexes. The electrocardiogram showed a markedly prolonged QTc interval of 550 ms with a notched T wave in lead V2. Phenytoin and propafenone were discontinued, and propranolol was initiated, but QTc prolongation persisted. The combination of severely prolonged QTc, characteristic T-wave morphology, and absence of structural heart disease redirected the diagnosis toward a repolarization channelopathy; genetic testing confirmed long-QT syndrome type 2 due to a pathogenic KCNH2 c.1814C>T variant. β-blocker therapy was optimized, QT-prolonging triggers were avoided, and a subcutaneous implantable cardioverter-defibrillator was implanted. Cascade genetic screening identified no additional KCNH2 carriers. One variant-negative sister had frequent idiopathic right ventricular outflow tract premature ventricular complexes and was referred for catheter ablation.
- Open Access
- 15 June 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (2) , 142-146
Un paciente, tres arritmias. Reporte de caso
Los pacientes posoperados cardíacos pueden tener más de una arritmia, debido a los cambios anatómicos propios de la cardiopatía congénita, así como a las cicatrices posquirúrgicas. La arritmia más frecuente en este tipo de pacientes es, por lejos, el flutter auricular, siendo la ablación con catéter el tratamiento ideal. Tras la ablación exitosa de la arritmia, es importante realizar maniobras de inducción por la posibilidad de que existan más macroreentradas. Se reporta el caso de una paciente de 55 años, con antecedentes de corrección quirúrgica de comunicación interauricular, que ingresó a un estudio electrofisiológico y ablación de flutter auricular con sistema tridimensional, con cero fluoroscopia y ecocardiograma intracardiaco. Durante el estudio, presentó tres arritmias diferentes (dos flutters y una taquicardia por reentrada del nodo AV), todas ablacionadas con éxito en el mismo procedimiento.
- 15 June 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (2) , 142-146
Open AccessUn paciente, tres arritmias. Reporte de caso
Los pacientes posoperados cardíacos pueden tener más de una arritmia, debido a los cambios anatómicos propios de la cardiopatía congénita, así como a las cicatrices posquirúrgicas. La arritmia más frecuente en este tipo de pacientes es, por lejos, el flutter auricular, siendo la ablación con catéter el tratamiento ideal. Tras la ablación exitosa de la arritmia, es importante realizar maniobras de inducción por la posibilidad de que existan más macroreentradas. Se reporta el caso de una paciente de 55 años, con antecedentes de corrección quirúrgica de comunicación interauricular, que ingresó a un estudio electrofisiológico y ablación de flutter auricular con sistema tridimensional, con cero fluoroscopia y ecocardiograma intracardiaco. Durante el estudio, presentó tres arritmias diferentes (dos flutters y una taquicardia por reentrada del nodo AV), todas ablacionadas con éxito en el mismo procedimiento.
- Open Access
- 28 March 2026
- Vol. 7 (1) , 52-60
The cardiovascular system and high-altitude exposure: from adaptation to disease. Part I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- 28 March 2026
- Vol. 7 (1) , 52-60
Open AccessThe cardiovascular system and high-altitude exposure: from adaptation to disease. Part I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- Open Access
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 61-69
El sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte II
En esta segunda parte de la revisión narrativa sobre la patología cardiovascular en gran altitud, se abordan las características clínicas y fisiopatológicas de la enfermedad coronaria aguda y crónica, las arritmias cardíacas y la hipertensión arterial en condiciones de hipoxia hipobárica. Finalmente, se destacan los principales vacíos en el conocimiento actual y las oportunidades para el desarrollo de investigaciones orientadas a comprender mejor estas enfermedades en las poblaciones que habitan permanentemente a gran altitud.
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 61-69
Open AccessEl sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte II
En esta segunda parte de la revisión narrativa sobre la patología cardiovascular en gran altitud, se abordan las características clínicas y fisiopatológicas de la enfermedad coronaria aguda y crónica, las arritmias cardíacas y la hipertensión arterial en condiciones de hipoxia hipobárica. Finalmente, se destacan los principales vacíos en el conocimiento actual y las oportunidades para el desarrollo de investigaciones orientadas a comprender mejor estas enfermedades en las poblaciones que habitan permanentemente a gran altitud.
- Open Access
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 52-60
El sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- 2 February 2026
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 7 (1) , 52-60
Open AccessEl sistema cardiovascular y la exposición a gran altitud: desde la adaptación a la enfermedad. Parte I
Exposure to high altitude constitutes a complex physiological challenge, driven primarily by hypobaric hypoxia and, in some settings, by extreme environmental conditions such as severe cold and increased ultraviolet radiation. At the cardiovascular level, this exposure elicits a range of acute and chronic adaptations, including activation of the sympathetic nervous system, pulmonary vasoconstriction, and vascular and ventricular remodelling. In the Andean region, millions of people live at elevations above 2,500 metres above sea level, rendering them particularly susceptible to these physiological adaptations and the associated cardiovascular alterations. This manuscript represents the first part of a narrative review and aims to synthesise the available scientific evidence on mechanisms of adaptation to high altitude, as well as the characteristics of pulmonary hypertension, heart failure, and congenital heart disease observed in both native high-altitude populations and individuals originating from low-altitude areas. In addition, it seeks to identify existing gaps in current knowledge of these conditions in order to promote the development of specific diagnostic, preventive, and therapeutic strategies aimed at improving cardiovascular health among populations residing at or temporarily exposed to high altitude.
- Open Access
- 18 October 2025
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 6 (4) , 239-244
Combined leadless pacing and subcutaneous defibrillation strategy in a high-risk patient: first case report from Peru
We present the case of a 51-year-old male with non-ischemic dilated cardiomyopathy and complete atrioventricular block, who was previously implanted with a cardiac resynchronization therapy defibrillator. The patient developed signs of pocket infection with a high risk of extrusion. Partial system extraction was performed, followed by 14 days of intravenous antibiotic therapy. Due to a history of ventricular fibrillation and permanent pacing dependency, and in the absence of viable transvenous access, a sequential implantation strategy was adopted using a leadless pacemaker (Micra AV, Medtronic) and a subcutaneous implantable cardioverter-defibrillator (EMBLEM, Boston Scientific). Both procedures were completed without complications, and the patient showed favorable recovery, with effective pacing, no arrhythmic recurrences, and no signs of infection at the six-month follow-up. This case illustrates the feasibility of a fully leadless approach in high-risk patients with contraindications to conventional transvenous systems.
- 18 October 2025
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 6 (4) , 239-244
Open AccessCombined leadless pacing and subcutaneous defibrillation strategy in a high-risk patient: first case report from Peru
We present the case of a 51-year-old male with non-ischemic dilated cardiomyopathy and complete atrioventricular block, who was previously implanted with a cardiac resynchronization therapy defibrillator. The patient developed signs of pocket infection with a high risk of extrusion. Partial system extraction was performed, followed by 14 days of intravenous antibiotic therapy. Due to a history of ventricular fibrillation and permanent pacing dependency, and in the absence of viable transvenous access, a sequential implantation strategy was adopted using a leadless pacemaker (Micra AV, Medtronic) and a subcutaneous implantable cardioverter-defibrillator (EMBLEM, Boston Scientific). Both procedures were completed without complications, and the patient showed favorable recovery, with effective pacing, no arrhythmic recurrences, and no signs of infection at the six-month follow-up. This case illustrates the feasibility of a fully leadless approach in high-risk patients with contraindications to conventional transvenous systems.
- Open Access
- 29 June 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (2) , 82-97
Las arritmias en la amiloidosis cardiaca
Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA.
- 29 June 2022
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 3 (2) , 82-97
Open AccessLas arritmias en la amiloidosis cardiaca
Cardiac amyloidosis (CA) is a form of cardiomyopathy characterized by the extracellular deposit of protein fibers in the myocardium, leading to the development of heart failure, arrhythmias, and electrical conduction system alterations. It is known that most cardiomyopathies have a close relationship with heart rhythm abnormalities, however, CA is specially related to different kinds of arrhythmias even in pre-diagnosis stages. Arrhythmias like atrial fibrillation are present in up to 70% of patients with CA associated with a high risk of cardioembolic complications independent of the risk stratification. Ventricular arrhythmias are frequent, but the use of implantable cardioverter defibrillator has not been demonstrated to improve survival. The Atrial-Ventricular node disease is also common, and is frequently associated with the implantation of a pacemaker, even in asymptomatic patients. In this review, we clarify the recommendations of the most current guidelines, summarize historical and contemporaneous data and describe evidence-based strategies for the management of arrhythmias and their complications in CA.